Tower Research Capital (TRC)’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Tower Research Capital (TRC)’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-263	Closed	-$3K	–	6601
2023 Q1	$3K	Buy	+263	New	+$2.7K	﹤0.01%	5295
2022 Q3	–	Sell	-742	Closed	-$7K	–	6784
2022 Q2	$7K	Buy	742 +464	+167%	+$4.64K	﹤0.01%	4863
2022 Q1	$3K	Buy	+278	New	+$2.76K	﹤0.01%	5469

Tower Research Capital (TRC)'s IQMD Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q2 2023, closing a stake of 263 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in IQMD in Q1 2022 and held it in 3 quarters. The position peaked at $7K in Q2 2022. 0 funds tracked by Wall St. Rank hold IQMD as of Q2 2023.

Tower Research Capital (TRC) reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 263 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $3K.
Tower Research Capital (TRC) first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 3 quarters.
Tower Research Capital (TRC)'s Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $7K in Q2 2022.
0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.